Professional
Added to YB: 2026-10-16
Pitch date: 2026-10-13
CLV.AX [bullish]
Clover Corporation Limited
+0.49%
current return
Author Info
Company Info
Clover Corporation Limited engages in the production, refining, and sale of natural oils and encapsulated powders in Australia, New Zealand, Asia, Europe, the Middle East, and the Americas.
Market Cap
AUD 169.4M
Pitch Price
AUD 1.02
Price Target
N/A
Dividend
2.45%
EV/EBITDA
9.15
P/E
16.29
EV/Sales
1.68
Sector
Chemicals
Category
growth
September 2026 Update - Clover Corporation Limited
CLV.AX (earnings): FY26 revenue rose 13% and NPAT 50%, extending recent momentum; a cyclical recovery and the Ecuador facility, now supplying 30% of raw-material inputs, have boosted profit. Free cash flow was negative as deliberate inventory growth followed strong customer forecasts, with H1 FY27 revenue guided above the prior corresponding period, though write-down risk remains. At 16x last year's NPAT, shares are not overly expensive, but CholineXcel carries capital and execution risk.
Read full article (2 min)